Testing of Ebola Vaccine on Humans Begins
BETHESDA, Maryland, August 29, 2014 (ENS) – Fast-tracked human testing of a vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health. The early-stage trial will test a vaccine co-developed by NIAID and GlaxoSmithKline on 20 healthy adults. […]